Updated 8/24/2018:

--------------------------------

 European Society of Cardiology (ESC) August 25-29, 2018; Munich, Germany

Symposium August 25th and Oral Presentation August 27th

Symposium: "LDL-c: Done Deal, Next Epigenetics?"

Oral Presentation "Apabetalone (RVX-208) Reduces Monocyte-Endothelial Cell Adhesion and Expression of Key Vascular Inflammation Markers in Monocytes, Endothelial Cells and in Inflamed Mouse Aorta" 

Clinical Trials on Alzheimer's Disease (CTAD)-Asia September 1-2, 2018; Shanghai, China

Oral presentation and Poster on September 1

Oral presentation: "Cognitive evaluation of treatment effects of the bromodomain and extra terminal domain inhibitor apabetalone: Design and baseline data of the cognition substudy of the BETonMACE Phase 3 cardiovascular trial." 

Poster: "Effect of the BET Protein Inhibitor Apabetalone on Serum Markers of Potential Importance for Cognitive Decline in Cardiovascular Disease Patients."

20th Annual Rodman & Renshaw Global Investment Conference, September 4-6, 2018, New York City

NewsMakers in the Biotech Industry, September 7th, 2018, New York City

Resverlogix and Zenith AGM's September 12, 2018

European Association for the Study of Diabetes (EASD) October 1-5, 2018

Oral Presentation October 3

"Apabetalone (RVX-208) an epigenetic modifier lowers risk of MACE in diabetes patients with CVD by affecting monocyte adhesion to endothelial cells"

BIO Investor Forum, October 17-18, 2018, San Francisco 

American Society for Nephrology (ASN) October 23-28, 2018; San Diego, CA

BIO-Europe November 5-7, 2018; Copenhagen, Denmark

American Heart Association (AHA) November 10-12, 2018; Chicago, IL

2019 events to keep an eye on

Biotech Showcase January 7-9, 2018; San Francisco, CA

American College Cardiology (ACC) March 16-18, 2019; New Orleans, LA (note: Late-Breaking Clinical Trial Submissions are open Wednesday, Oct. 24 – Wednesday, Dec. 5, 2018). This is prime time possiblility for BETonMACE. First big cardio conference of the new year. Many big cardio outcomes trials present full trial results here.

BIO-Europe Spring March 25-27, 2018; Vienna, Austria

Vascular Discovery: From Genes to Medicine (Formerly ATVB:PVD): May 2019

European Renal Association – European Dialysis and Transplant Association (ERA-EDTA): June 2019

BIO-International June 2019

American Diabetes Association (ADA) June 2019